POTASSIUM CHLORIDE IN LACTATED RINGERS AND DEXTROSE- potassium chloride, sodium chloride, calcium chloride, sodium lactate, and dextrose monohydrate injection, solution United States - English - NLM (National Library of Medicine)

potassium chloride in lactated ringers and dextrose- potassium chloride, sodium chloride, calcium chloride, sodium lactate, and dextrose monohydrate injection, solution

icu medical inc. - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid, unspecified form - unii:33x04xa5at), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - this solution is indicated in patients requiring parenteral administration of potassium chloride and the replacement of extracellular losses of fluids and electrolytes with minimal carbohydrate calories. solutions containing potassium chloride are contraindicated in diseases where high potassium levels may be encountered. solutions containing lactate are not for use in the treatment of lactic acidosis. to open tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. some opacity of the plastic due to moisture absorption during the sterilization process may be observed. this is normal and does not affect the solution quality or safety. the opacity will diminish gradually. to add medication - prepare additive port. prepare additive port. - using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw needle after injecting medication. using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw needle after injecting medication. - the additive port may be protected by covering with an additive cap. the additive port may be protected by covering with an additive cap. - mix container contents thoroughly. mix container contents thoroughly. preparation for administration (use aseptic technique) - close flow control clamp of administration set. close flow control clamp of administration set. - remove cover from outlet port at bottom of container. remove cover from outlet port at bottom of container. - insert piercing pin of administration set into port with a twisting motion until the set is firmly seated. note: see full directions on administration set carton. insert piercing pin of administration set into port with a twisting motion until the set is firmly seated. note: see full directions on administration set carton. - suspend container from hanger. suspend container from hanger. - squeeze and release drip chamber to establish proper fluid level in chamber. squeeze and release drip chamber to establish proper fluid level in chamber. - open flow control clamp and clear air from set. close clamp. open flow control clamp and clear air from set. close clamp. - attach set to venipuncture device. if device is not indwelling, prime and make venipuncture. attach set to venipuncture device. if device is not indwelling, prime and make venipuncture. - regulate rate of administration with flow control clamp. regulate rate of administration with flow control clamp. warning: do not use flexible container in series connections.

Gaviscon Liquid Sachets Oral Suspension Sodium alginate 500mg, Sodium bicarbonate 267mg, Calcium carbonate 160mg Ireland - English - HPRA (Health Products Regulatory Authority)

gaviscon liquid sachets oral suspension sodium alginate 500mg, sodium bicarbonate 267mg, calcium carbonate 160mg

reckitt benckiser ireland ltd - sodium alginate; sodium bicarbonate; calcium carbonate - oral suspension in sachet - 500 mg+267 mg+160 milligram(s) - other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord); alginic acid

CALCIUM - D - SOURCE Israel - English - Ministry of Health

calcium - d - source

gsk consumer healthcare, israel ltd - calcium carbonate; calcium lactate gluconate; colecalciferol - tablets effervescent - calcium lactate gluconate 1358 mg; calcium carbonate 1050 mg; colecalciferol 4 mg - calcium lactate gluconate - calcium lactate gluconate - calcium and vitamin d supplement. calcium helps in the maintenance of bones and teeth. vitamin d helps in the absorption and use of calcium.

Gaviscon Advance Oral Suspension Sodium alginate 500 mg, Potassium hydrogen carbonate 100 mg. Ireland - English - HPRA (Health Products Regulatory Authority)

gaviscon advance oral suspension sodium alginate 500 mg, potassium hydrogen carbonate 100 mg.

reckitt benckiser ireland ltd - potassium hydrogen carbonate; sodium alginate - oral suspension - 500mg/ 5 ml+100 mg/5ml - other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)

Gaviscon Advance Peppermint Oral Suspension Sachets   Sodium Alginate 500mg, Potassium hydrogen carbonate 100 mg Oral suspension. Ireland - English - HPRA (Health Products Regulatory Authority)

gaviscon advance peppermint oral suspension sachets sodium alginate 500mg, potassium hydrogen carbonate 100 mg oral suspension.

reckitt benckiser ireland ltd - sodium alginate; potassium hydrogen carbonate - oral suspension - 1000/200 milligram(s) - other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord); alginic acid

Gaviscon Advance Peppermint Oral Suspension Sodium alginate 500 mg, Potassium hydrogen carbonate 100 mg. Ireland - English - HPRA (Health Products Regulatory Authority)

gaviscon advance peppermint oral suspension sodium alginate 500 mg, potassium hydrogen carbonate 100 mg.

reckitt benckiser ireland ltd - sodium alginate; potassium hydrogen carbonate - oral suspension - 1000/200 milligram(s) - other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord); alginic acid

Gaviscon Extra Oral Suspension Sodium alginate 500 mg Sodium bicarbonate 213 mg Calcium carbonate 325 mg Ireland - English - HPRA (Health Products Regulatory Authority)

gaviscon extra oral suspension sodium alginate 500 mg sodium bicarbonate 213 mg calcium carbonate 325 mg

reckitt benckiser ireland ltd - sodium alginate; sodium bicarbonate; calcium carbonate - oral suspension - 500 mg+213 mg+325 milligram(s) - other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord); alginic acid

Gaviscon Extra Liquid Sachets Peppermint Flavour Oral SuspensionSodium Alginate 500 mg/10 ml Sodium Bicarbonate 213 mg/10 ml Calcium Carbonate 325 mg/10 ml Ireland - English - HPRA (Health Products Regulatory Authority)

gaviscon extra liquid sachets peppermint flavour oral suspensionsodium alginate 500 mg/10 ml sodium bicarbonate 213 mg/10 ml calcium carbonate 325 mg/10 ml

reckitt benckiser ireland ltd - sodium alginate; sodium bicarbonate; calcium carbonate - oral suspension in sachet - 500 mg/10 ml + 213 mg/10 ml + 325 milligram/ 10 millilitre - other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord); alginic acid

Gaviscon Oral Suspension 500mg/10ml Sodium Alginate 267mg/10ml Sodium Bicarbonate 160mg/10ml Calcium Carbonate Ireland - English - HPRA (Health Products Regulatory Authority)

gaviscon oral suspension 500mg/10ml sodium alginate 267mg/10ml sodium bicarbonate 160mg/10ml calcium carbonate

reckitt benckiser ireland ltd - sodium bicarbonate; calcium carbonate; sodium alginate - oral suspension - 500mg/10 ml+267mg/10ml+160 milligram/ 10 millilitre - antacids, other combinations; other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)

GAVISCON DUAL ACTION peppermint flavour chewable tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

gaviscon dual action peppermint flavour chewable tablet blister pack

reckitt benckiser pty ltd - sodium alginate, quantity: 250 mg; sodium bicarbonate, quantity: 106.5 mg; calcium carbonate, quantity: 187.5 mg - tablet, chewable - excipient ingredients: magnesium stearate; carmellose sodium; aspartame; macrogol 20000; acesulfame potassium; copovidone; xylitol; carmoisine aluminium lake; mannitol; flavour - relief of the symptoms associated with reflux oesophagitis, hiatus hernia and all cases of epigastric distress where the underlying cause is gastro-oesophageal reflux. fast, soothing relief of heartburn and acid indigestion due to gastro-oesophageal reflux.